| Nome |
# |
|
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF), file e9031bb8-1f54-46fb-a644-94aee6920a7b
|
221
|
|
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations, file 44838425-d979-4432-9f8f-63d4ec6f5c89
|
199
|
|
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?, file e2913fde-b9e7-f688-e053-3705fe0a67e0
|
190
|
|
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure?, file 67d0bada-bd04-4c00-a61e-84e96dff07b3
|
173
|
|
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?, file 84c60f9d-55c6-4004-88b6-59daa9b925a1
|
166
|
|
The History and Mystery of Alveolar Epithelial Type II Cells:
Focus on Their Physiologic and Pathologic Role in Lung, file e2913fdd-de58-f688-e053-3705fe0a67e0
|
126
|
|
The Treatment of Lung Involvement in Systemic Sclerosis, file e2913fdd-f11e-f688-e053-3705fe0a67e0
|
91
|
|
Chronic Thromboembolic Pulmonary Hypertension: An Update, file e2913fde-c31c-f688-e053-3705fe0a67e0
|
75
|
|
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction, file 6e4375b0-5040-48cc-be18-a403f433b7b2
|
68
|
|
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO), file e2913fdd-eee0-f688-e053-3705fe0a67e0
|
64
|
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file e968ece1-dd07-4be2-86de-dc40964e9100
|
62
|
|
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS, file e2913fdf-bbba-f688-e053-3705fe0a67e0
|
53
|
|
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening, file e2913fde-b8f2-f688-e053-3705fe0a67e0
|
52
|
|
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update, file e2913fdf-8d26-f688-e053-3705fe0a67e0
|
42
|
|
Prolonged Low-Dose Methylprednisolone in Patients With
Severe COVID-19 Pneumonia, file e2913fde-0a60-f688-e053-3705fe0a67e0
|
40
|
|
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension, file 218650f7-1914-4730-ba13-59a8d1782fcc
|
39
|
|
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?, file e2913fdd-eaf3-f688-e053-3705fe0a67e0
|
39
|
|
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients, file e2913fde-a4fc-f688-e053-3705fe0a67e0
|
34
|
|
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study, file 5944f585-c99b-4132-8259-2ecac0c4d6f0
|
32
|
|
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, file e2913fdf-7d3d-f688-e053-3705fe0a67e0
|
32
|
|
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study, file e2913fdd-b0d3-f688-e053-3705fe0a67e0
|
30
|
|
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis, file e2913fde-2c33-f688-e053-3705fe0a67e0
|
29
|
|
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?, file c0d87d73-3e73-4dbf-a216-3aad758e3e60
|
28
|
|
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated, file e2913fde-73b1-f688-e053-3705fe0a67e0
|
28
|
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file 23f534e4-f875-484b-bef6-3d0914b452ae
|
27
|
|
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy, file 0af62be6-de83-4205-96d4-24da9c0b68b7
|
26
|
|
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?, file e2913fde-b6c1-f688-e053-3705fe0a67e0
|
23
|
|
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, file e2913fdf-7d3c-f688-e053-3705fe0a67e0
|
23
|
|
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS, file e2913fdf-bda0-f688-e053-3705fe0a67e0
|
22
|
|
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings, file 497e9370-0474-4a64-830a-bac777c79261
|
20
|
|
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia, file e2913fdf-676b-f688-e053-3705fe0a67e0
|
20
|
|
Host-Based Treatments for Severe COVID-19, file 27d1577a-0ea2-440f-ab53-279c95ddeabd
|
19
|
|
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support, file e2913fdf-8e09-f688-e053-3705fe0a67e0
|
19
|
|
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy, file 215bd64b-857f-4621-b7b9-c5007b22f55e
|
17
|
|
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases?, file e2913fdd-b290-f688-e053-3705fe0a67e0
|
17
|
|
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?, file e2913fde-a70c-f688-e053-3705fe0a67e0
|
17
|
|
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients, file e2913fdf-1efc-f688-e053-3705fe0a67e0
|
16
|
|
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?, file e2913fdf-bcf3-f688-e053-3705fe0a67e0
|
16
|
|
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation, file 0e01082c-9669-440c-adf8-f465cb5270e5
|
15
|
|
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier, file 9697159c-f305-41b0-b2be-e65e3569f1f1
|
15
|
|
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients, file e2913fde-2662-f688-e053-3705fe0a67e0
|
15
|
|
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS), file 8018e24f-9781-48aa-892d-f71554930e1c
|
14
|
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file 848c7270-bb41-40c6-8734-4befcc1c21cf
|
13
|
|
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma, file bdba64bb-e983-45c6-aa76-8ae24138e84d
|
12
|
|
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints, file e6202480-4d19-4619-8766-37511251f944
|
11
|
|
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria, file 11ae49ec-1559-4734-a3e5-0f518c4b8435
|
9
|
|
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?, file b596e307-d393-4e0d-8039-16701f1639ac
|
9
|
|
Prolonged Low-Dose Methylprednisolone in Patients With
Severe COVID-19 Pneumonia, file e2913fde-0a61-f688-e053-3705fe0a67e0
|
9
|
|
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study, file e2913fde-9672-f688-e053-3705fe0a67e0
|
9
|
|
Biomarkers in Systemic Sclerosis: An Overview, file f5ecf29f-41d7-4419-ae58-dbff3ed7a87b
|
9
|
|
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma, file 2992acdd-b95b-43b3-8940-ef3354ad7513
|
8
|
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file 41daaa67-50bf-4957-a147-284ce0e3896a
|
8
|
|
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier, file 9cdd3a43-f3e5-4578-aa47-659698be1bbd
|
8
|
|
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial, file f5939286-5868-4588-b232-62356cde3988
|
8
|
|
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria, file 30f513d6-5bf6-449f-8db7-8ef52920f297
|
7
|
|
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story?, file 5809d823-7da7-4259-b8d7-57c983bbfd6b
|
6
|
|
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19, file 7064c102-bf2b-4cd8-9c65-d5aeabde2b8a
|
6
|
|
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma, file a4fd1271-7da6-4314-951a-e5fb7cdf31f8
|
6
|
|
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis, file 378b94e0-6397-4f19-be60-3691b3c0f4c2
|
5
|
|
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?, file 62cbc936-f3fc-4d88-8bd2-14079dac764b
|
5
|
|
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, file a5713631-c7e8-4b62-8cf4-36a65bbb6af8
|
5
|
|
Alveolar Epithelial Type II Cells, file e2913fde-edc6-f688-e053-3705fe0a67e0
|
4
|
|
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity, file ef76bf49-8cd4-4611-bdb6-fb37d505f83d
|
4
|
|
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study, file ae6d40fa-0106-410f-8865-06d3d014b9b3
|
3
|
|
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study), file d85371fa-4875-44c9-aeac-dee0af51a366
|
3
|
|
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study, file 75d2ff79-740f-43cc-bfbb-246d73a1db4c
|
2
|
|
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations, file e2913fdd-edfa-f688-e053-3705fe0a67e0
|
2
|
|
Caution When Comparing the Impact of Corticosteroids in COVID-19, file e2913fde-35ca-f688-e053-3705fe0a67e0
|
2
|
|
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study, file 57f6281e-7fe3-4346-8d6e-db197933e8bf
|
1
|
|
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study, file 8faff067-f6e0-40ba-90da-106787bb6114
|
1
|
|
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?, file e2913fdf-5932-f688-e053-3705fe0a67e0
|
1
|
| Totale |
2.430 |